|
|
PRESS RELEASE:
REPURCHASE OF OWN SHARES IN THE CONTEXT OF THE LIQUIDITY CONTRACT
REGULATED INFORMATION
Wednesday 15 August 2018 – 6:00 pm CET
Repurchase of own shares in the context of... See more |
|
|
|
| |
|
| |
|
|
FDA Accepts New Drug Application NDA to review Midazolam Nasal Spray, an investigational product for the acute treatment of seizure clustersMidazolam Nasal Spray has been granted orphan drug designation by the United States Food and Drug Administration US FDA for the rescue treatment of seizures in patients who require control of intermittent bouts of increased seizure activity e.g. seizure... See more |
|
|
|
| |
|
| |
|
|
Transparency notification BlackRock, Inc.Brussels Belgium, 10 August 2018 – 20:00 CEST – regulated information1. Summary of the notificationPursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received a transparency notification from BlackRock, Inc. having its registered office at 55 East 52nd Street, New York, NY, 10055,... See more |
|
|
|
| |
|
| |
|
|
INFORMATION RÉGLEMENTÉE
10 août 2018
Actions propres
Dans le cadre du programme de Rachat d'actions propres autorisé par l'Assemblée Générale des actionnaires le 20 mai 2014, Econocom Group SE a procédé, durant la période du 03/08/2018 au 09/08/2018, aux transactions suivantes sur l'action Econocom Group :
Date
Méthode de... See more |
|
|
|
| |
|
| |
|
|
Transparency notifications BlackRock, Inc.4 notifications referring to situation on 1, 2, 3 and 6 August 2018Threshold crossed: 5%Latest holding: 5.04%Brussels Belgium, 8 August 2018 – 20:00 CEST – regulated information1. Summary of the notificationsPursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received 4 transparency... | |
Search :
